نتائج البحث

T‐cell responses in COVID‐19 survivors 6−8 months after infection: A longitudinal cohort study in Pune.

• Authors : Suryawanshi, Poonam¹ (AUTHOR); Patil‐Takbhate, Bhagyashri¹ (AUTHOR); Athavale, Prachi² (AUTHOR)

• Source: Immunity, Inflammation & Disease. Jun2024, Vol. 12 Issue 6, p1-15. 15p.

تفاصيل العنوان

Prevalence of SARS‐CoV‐2 in domestic cats (Felis catus) during COVID‐19 pandemic in Latvia.

• Authors : Mūrniece, Gundega¹ (AUTHOR) ; Šteingolde, Žanete² (AUTHOR); Cvetkova, Svetlana² (AUTHOR)

• Source: Veterinary Medicine & Science. May2024, Vol. 10 Issue 3, p1-14. 14p.

تفاصيل العنوان

Seroprevalence of SARS‐CoV‐2 infection in the general population of Nepal during the first and second generalized waves of the COVID‐19 pandemic—2020–2021.

• Authors : Paudel, Krishna Prasad¹ (AUTHOR) ; Samuel, Reuben² (AUTHOR) ; Jha, Runa³ (AUTHOR)

• Source: Influenza & Other Respiratory Viruses. Dec2023, Vol. 17 Issue 12, p1-11. 11p.

تفاصيل العنوان

Evolution of seroprevalence to SARS‐CoV‐2 in blood donors in Sarajevo Canton, Federation of Bosnia and Herzegovina: Cross‐sectional and longitudinal studies.

• Authors : Musa, Sanjin^1,2 (AUTHOR) ; Catovic Baralija, Elma³ (AUTHOR); Ivey Sawin, Veronica¹ (AUTHOR)

• Source: Influenza & Other Respiratory Viruses. Aug2023, Vol. 17 Issue 8, p1-10. 10p.

تفاصيل العنوان

Structure and epitope of a neutralizing monoclonal antibody that targets the stem helix of β coronaviruses.

• Authors : Deshpande, Ashlesha¹ (AUTHOR); Schormann, Nobert² (AUTHOR); Piepenbrink, Mike S.³ (AUTHOR)

Subjects: *SARS-CoV-2; *MONOCLONAL antibodies; *MIDDLE East respiratory syndrome

• Source: FEBS Journal. Jul2023, Vol. 290 Issue 13, p3422-3435. 14p.

تفاصيل العنوان

Anti‐Coronaviral Nanocluster Restrain Infections of SARS‐CoV‐2 and Associated Mutants through Virucidal Inhibition and 3CL Protease Inactivation.

• Authors : Tang, Hao¹ (AUTHOR); Qin, Hongbo² (AUTHOR); He, Shiting² (AUTHOR)

• Source: Advanced Science. 4/5/2023, Vol. 10 Issue 13, p1-13. 13p.

تفاصيل العنوان

How Asymptomatic Transmission Influences Mitigation and Suppression Strategies during a Pandemic.

• Authors : Biggs, Adam T.¹ (AUTHOR) ; Littlejohn, Lanny F.¹ (AUTHOR)

Subjects: *VIRAL transmission; *PANDEMICS; *SARS-CoV-2

• Source: Risk Analysis: An International Journal. Apr2023, Vol. 43 Issue 4, p649-659. 11p. 1 Chart, 4 Graphs.

تفاصيل العنوان

Risk assessment of banknotes as a fomite of SARS‐CoV‐2 in cash payment transactions.

• Authors : Schijven, Jack F.^1,2 (AUTHOR) ; Wind, Mark³ (AUTHOR); Todt, Daniel^4,5 (AUTHOR)

Subjects: *COVID-19 pandemic; *BANK notes; *SARS-CoV-2

• Source: Risk Analysis: An International Journal. Apr2023, Vol. 43 Issue 4, p700-708. 9p. 1 Diagram, 3 Charts, 2 Graphs.

تفاصيل العنوان

A pharmacokinetic drug–drug interaction study between rosuvastatin and emvododstat, a potent anti‐SARS‐CoV‐2 (COVID‐19) DHODH (dihydroorotate dehydrogenase) inhibitor.

• Authors : Morton, Terri L.¹ (AUTHOR); Laskin, Oscar L.¹ (AUTHOR); Kaushik, Diksha¹ (AUTHOR)

• Source: Pharmacology Research & Perspectives. Apr2023, Vol. 11 Issue 2, p1-6. 6p.

تفاصيل العنوان

Cyclophilin A‐mediated mitigation of coronavirus SARS‐CoV‐2.

• Authors : Sekhon, Simranjeet Singh¹ (AUTHOR); Shin, Woo‐Ri¹ (AUTHOR); Kim, Sang Yong² (AUTHOR)

• Source: Bioengineering & Translational Medicine. Mar2023, Vol. 8 Issue 2, p1-16. 16p.

تفاصيل العنوان